Author Archives: Jennifer Walker-Journey
Could your antidepressant be doing more harm than good?
Depression is a condition that goes beyond “the blues,” and some statistics show that as many as 10 percent of adults in the United States will experience depressive symptoms at some point in their lives. Symptoms can include sleeping disorders,
Non-surgical procedure an alternative to blood thinners for atrial fibrillation patients
A non-surgical procedure could help prevent strokes in patients with a heart condition known as atrial fibrillation, and eliminate the need for blood thinners. The procedure, identified by scientists from the Bluhm Cardiovascular Institute in Illinois, involves tying off the
Off label use of Depakote unnecessarily exposed users to side effects
Abbott Laboratories will pay $1.5 billion in fees and settlements for marketing its anti-seizure drug Depakote for unapproved uses, a violation that has unnecessarily exposed thousands of people to potentially dangerous side effects, including birth defects.
Diabetics urged to avoid Actos due to cancer risk
People with type 2 diabetes should use the drug Actos (pioglitazone) only if all other options have failed, and people with pre-diabetes should never use it, says Consumer Reports, the well-known consumer watchdog organization.
Generic Testim will carry same black box warning as brand name
Watson Laboratories Inc. has filed an application to market a generic version of Auxilium Pharmaceuticals’ testosterone gel, Testim. Last year, the testosterone-containing treatment generated revenues of $207.9 million for Auxillium.
Abbott to pay $1.5 billion for marketing Depakote for unapproved uses
Abbott Laboratories has admitted to promoting its anti-seizure drug Depakote for uses that were not approved by the Food and Drug Administration (FDA), and has agreed to pay $1.5 billion in criminal fines and civil settlement fees. Deputy Attorney General
